Related Experiment Video
Updated: Aug 9, 2026
06:18
An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
Published on: August 13, 2019
Dehydroepiandrosterone therapy as female androgen replacement
1Center for Sexual Function, Lahey Clinic Northshore, One Essex Center Drive, Peabody, MA 01960, USA.
Seminars in Reproductive Medicine
|April 25, 2006
Summary
Dehydroepiandrosterone (DHEA) supplementation may benefit women with adrenal insufficiency but its effects on sexual function in healthy women remain controversial. More research is needed to clarify DHEA
Area of Science:
- Endocrinology
- Reproductive Health
- Hormone Therapy
Background:
- Dehydroepiandrosterone (DHEA) is a key androgen precursor produced by the adrenal glands.
- DHEA influences sexual function, metabolism, and well-being through various mechanisms.
- Low DHEA levels are linked to sexual dysfunction in women and various health conditions.
Purpose of the Study:
- To review the effects of DHEA supplementation in women.
- To evaluate DHEA's efficacy in adrenal insufficiency versus healthy individuals.
- To address the controversy surrounding DHEA supplementation in euadrenal women.
Main Methods:
- Literature review of studies on DHEA supplementation in women.
- Analysis of DHEA's impact on sexual function, metabolism, and well-being.
- Comparison of DHEA effects in women with and without adrenal insufficiency.
Main Results:
- DHEA supplementation shows benefits in women with adrenal insufficiency.
- Results are conflicting regarding DHEA's positive effects in healthy euadrenal women.
- Efficacy for sexual function, metabolism, and well-being in healthy women is uncertain.
Conclusions:
- DHEA supplementation is beneficial for women with adrenal insufficiency.
- The role of DHEA supplementation in healthy women requires further investigation.
- More research is essential to determine the safety and efficacy of DHEA for female androgen insufficiency.
Related Concept Videos
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
01:28Menopause
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
01:23Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
01:18Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
01:40Hormonal Regulation
Hormones regulate a significant portion of digestion through activation of the neuroendocrine system. The neuroendocrine system of digestion contains many different hormones all with multiple functions that are both, directly and indirectly, involved in digestion.
01:28Infertility in Females
Female infertility is defined as the inability to conceive after a year of regular, unprotected intercourse and affects about 10–15% of couples worldwide. The primary cause of female infertility is ovulatory disorders, which hinder the release of eggs. These disorders can be classified as hypothalamic amenorrhea, polycystic ovarian syndrome (PCOS), premature ovarian failure, and hyperprolactinemic anovulation disorders.
Endometriosis, a condition characterized by abnormal growth of endometrial...
Endometriosis, a condition characterized by abnormal growth of endometrial...